Guangzhou Improve Med Instrument Net Assets

Latest as of March 2026: CN¥677.10 Million CNY ≈ $99.08 Million USD

Guangzhou Improve Med Instrument net assets. Based on the latest financial reports, Guangzhou Improve Med Instrument (300030) has net assets worth CN¥677.10 Million CNY (≈ $99.08 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.02 Billion ≈ $149.71 Million USD) and total liabilities (CN¥346.01 Million ≈ $50.63 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 300030 net asset momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥677.10 Million
% of Total Assets	66.18%
Annual Growth Rate	20.37%
5-Year Change	-36.42%
10-Year Change	-31.34%
Growth Volatility	141.88

Net Assets of Guangzhou Improve Med Instrument (2006–2025)

Net assets of Guangzhou Improve Med Instrument from 2006 to 2025. This chart illustrates how Guangzhou Improve Med Instrument's net assets have evolved over time, based on quarterly financial data. See net asset quality index of Guangzhou Improve Med Instrument to measure how much of total assets are equity-financed.

Annual Net Assets for Guangzhou Improve Med Instrument (2006–2025)

The table below shows the annual net assets of Guangzhou Improve Med Instrument from 2006 to 2025. For live market cap and overall valuation, see 300030 market cap.

Year	Net Assets	Change
2025-12-31	CN¥655.10 Million ≈ $95.86 Million	+1.74%
2024-12-31	CN¥643.86 Million ≈ $94.22 Million	-15.54%
2023-12-31	CN¥762.33 Million ≈ $111.55 Million	-7.10%
2022-12-31	CN¥820.61 Million ≈ $120.08 Million	-20.36%
2021-12-31	CN¥1.03 Billion ≈ $150.78 Million	+2.75%
2020-12-31	CN¥1.00 Billion ≈ $146.74 Million	+19.63%
2019-12-31	CN¥838.26 Million ≈ $122.66 Million	+2.79%
2018-12-31	CN¥815.47 Million ≈ $119.33 Million	-15.38%
2017-12-31	CN¥963.72 Million ≈ $141.02 Million	+1.00%
2016-12-31	CN¥954.18 Million ≈ $139.63 Million	+2.55%
2015-12-31	CN¥930.46 Million ≈ $136.16 Million	+18.98%
2014-12-31	CN¥782.00 Million ≈ $114.43 Million	+1.20%
2013-12-31	CN¥772.70 Million ≈ $113.07 Million	+12.32%
2012-12-31	CN¥687.93 Million ≈ $100.67 Million	+6.12%
2011-12-31	CN¥648.25 Million ≈ $94.86 Million	+9.40%
2010-12-31	CN¥592.55 Million ≈ $86.71 Million	+5.15%
2009-12-31	CN¥563.53 Million ≈ $82.46 Million	+615.80%
2008-12-31	CN¥78.73 Million ≈ $11.52 Million	+35.12%
2007-12-31	CN¥58.27 Million ≈ $8.53 Million	+201.39%
2006-12-31	CN¥19.33 Million ≈ $2.83 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Guangzhou Improve Med Instrument's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 1738.8% over the analyzed period, potentially due to dividend distributions or operating losses.

Guangzhou Improve Med Instrument Net Assets Breakdown (December 2025)

Guangzhou Improve Med Instrument net assets breakdown by equity component as of December 2025.

Component	Amount	Percentage
Other Components	CN¥757.08 Million	122.04%
Total Equity	CN¥620.34 Million	100.00%

Guangzhou Improve Med Instrument Competitors by Market Cap

The table below lists competitors of Guangzhou Improve Med Instrument ranked by their market capitalization.

Company	Market Cap
Ideal Group S.A AT:INTEK	$321.33 Million
Myriad Genetics Inc NASDAQ:MYGN	$321.38 Million
Gospell Digital Technology Co Ltd SHE:002848	$321.40 Million
Xinjiang Haoyuan Natural Gas Co Ltd SHE:002700	$321.40 Million
Shenzhen Prolto Supply Chain Management Co Ltd SHE:002769	$321.21 Million
Unggul Indah Cahaya Tbk JK:UNIC	$321.20 Million
Perfect Group Corp Ltd Class A SHG:603059	$321.17 Million
Putnam Premier Income Trust NYSE:PPT	$321.11 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Guangzhou Improve Med Instrument's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 606,734,458 to 620,335,334, a change of 13,600,876 (2.2%).
Net income of 14,530,384 contributed positively to equity growth.
Dividend payments of 5,496,454 reduced retained earnings.
Other comprehensive income decreased equity by 53,869,765.
Other factors increased equity by 58,436,711.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥14.53 Million	+2.34%
Dividends Paid	CN¥5.50 Million	-0.89%
Other Comprehensive Income	CN¥-53.87 Million	-8.68%
Other Changes	CN¥58.44 Million	+9.42%
Total Change	CN¥-	2.24%

Book Value vs Market Value Analysis

This analysis compares Guangzhou Improve Med Instrument's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 3.54x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 66.82x to 3.54x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2006-12-31	CN¥0.11	CN¥7.10	x
2007-12-31	CN¥0.32	CN¥7.10	x
2008-12-31	CN¥0.40	CN¥7.10	x
2009-12-31	CN¥2.67	CN¥7.10	x
2010-12-31	CN¥2.04	CN¥7.10	x
2011-12-31	CN¥2.11	CN¥7.10	x
2012-12-31	CN¥2.18	CN¥7.10	x
2013-12-31	CN¥2.37	CN¥7.10	x
2014-12-31	CN¥2.48	CN¥7.10	x
2015-12-31	CN¥3.00	CN¥7.10	x
2016-12-31	CN¥3.10	CN¥7.10	x
2017-12-31	CN¥3.42	CN¥7.10	x
2018-12-31	CN¥2.61	CN¥7.10	x
2019-12-31	CN¥2.57	CN¥7.10	x
2020-12-31	CN¥3.26	CN¥7.10	x
2021-12-31	CN¥3.23	CN¥7.10	x
2022-12-31	CN¥2.53	CN¥7.10	x
2023-12-31	CN¥2.29	CN¥7.10	x
2024-12-31	CN¥1.96	CN¥7.10	x
2025-12-31	CN¥2.01	CN¥7.10	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Guangzhou Improve Med Instrument utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 2.34%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 2.99%
• Asset Turnover: 0.47x
• Equity Multiplier: 1.66x
Recent ROE (2.34%) is below the historical average (4.45%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2006	43.16%	18.91%	1.10x	2.07x	CN¥6.41 Million
2007	22.64%	18.24%	0.98x	1.27x	CN¥7.36 Million
2008	25.99%	19.78%	0.73x	1.80x	CN¥12.59 Million
2009	4.77%	19.11%	0.21x	1.17x	CN¥-29.45 Million
2010	4.90%	17.50%	0.25x	1.10x	CN¥-30.23 Million
2011	5.75%	14.29%	0.35x	1.15x	CN¥-26.41 Million
2012	5.80%	12.32%	0.40x	1.19x	CN¥-27.13 Million
2013	6.74%	11.62%	0.45x	1.29x	CN¥-22.31 Million
2014	7.27%	11.49%	0.45x	1.40x	CN¥-19.94 Million
2015	4.33%	7.30%	0.38x	1.56x	CN¥-52.23 Million
2016	3.23%	5.89%	0.35x	1.56x	CN¥-63.96 Million
2017	1.17%	2.03%	0.31x	1.83x	CN¥-84.33 Million
2018	-16.87%	-24.87%	0.36x	1.86x	CN¥-217.88 Million
2019	3.11%	4.53%	0.38x	1.80x	CN¥-57.57 Million
2020	16.26%	17.68%	0.53x	1.75x	CN¥62.54 Million
2021	1.86%	2.32%	0.44x	1.82x	CN¥-81.45 Million
2022	-25.28%	-27.90%	0.46x	1.99x	CN¥-276.73 Million
2023	-8.74%	-9.80%	0.45x	1.97x	CN¥-135.51 Million
2024	-19.43%	-20.28%	0.47x	2.05x	CN¥-178.58 Million
2025	2.34%	2.99%	0.47x	1.66x	CN¥-47.50 Million

Industry Comparison

This section compares Guangzhou Improve Med Instrument's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

Industry: Medical Instruments & Supplies
Average net assets among peers: $1,491,312,247
Average return on equity (ROE) among peers: 14.19%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Guangzhou Improve Med Instrument (300030)	CN¥677.10 Million	43.16%	0.51x	$321.23 Million
Beijing Centergate Technologies Holding Co Ltd (000931)	$798.63 Million	7.58%	4.03x	$418.78 Million
Blue Sail Medical Co Ltd (002382)	$961.83 Million	5.32%	0.71x	$825.68 Million
Andon Health Co Ltd (002432)	$757.75 Million	0.92%	0.08x	$3.69 Billion
Allmed Medical Products Co Ltd Class A (002950)	$2.92 Billion	39.60%	0.66x	$780.25 Million
QITIAN Technology Group Co Ltd (300061)	$3.58 Billion	8.33%	0.22x	$745.42 Million
Shanghai Tofflon Science Tech (300171)	$113.69 Million	40.44%	1.35x	$1.55 Billion
Truking Technology Ltd (300358)	$2.32 Billion	6.92%	0.71x	$958.51 Million
Jiangxi Sanxin Medtec Co Ltd (300453)	$1.41 Billion	16.14%	0.58x	$730.36 Million
Shenyang Xingqi Pharmaceutical Co Ltd (300573)	$554.58 Million	2.46%	0.28x	$1.30 Billion

About Guangzhou Improve Med Instrument

SHE:300030 China Medical Instruments & Supplies

Market Cap

$321.23 Million

CN¥2.20 Billion CNY

Market Cap Rank

#14226 Global

#4203 in China

Share Price

CN¥7.10

Change (1 day)

-3.40%

52-Week Range

CN¥5.80 - CN¥8.60

All Time High

CN¥22.76